PDA 2023

The Universe of Pre-Filled Syringes and Injection Devices Conference 

2023 PDA Universe of Pre-Filled Syringes and Injection Devices Conference was packed with captivating speakers and thought-provoking discussions. Thank you to the many customers and colleagues who visited our booth. We value the thought-provoking conversations.

In Case You Missed It

Phillips-Medisize Commercial Director Iain Simpson conducted a Tech Talk speaker presentation during the PDA 2023 Universe of Pre-Filled Syringes and Injection Devices Conference in Gothenburg, Sweden.

Entitled “Electromechanical Autoinjectors – a Versatile Platform for Diverse Injectable Drug Portfolios,” the presentation addresses your most advanced injectable drug device platform and pharma innovation challenges with these timely and specialized insights, which explore:  

  • Autoinjector platform efficiency advantages and technology options  
  • High-concentration drug formulations – a promising way to deliver high drug payloads 
  • Injector force requirements for the delivery of viscous drugs 
  • Key features of the electromechanical, reusable Aria Smart Autoinjector from Phillips-Medisize 

Here’s a brief snapshot of the widely respected credentials of Iain Simpson: 

  • Part of a global team developing industry-leading solutions and platforms for drug delivery, digital medicine and connected health 
  • 30+ years of experience in multi-disciplinary technology and product development 
  • 20 years of specialized healthcare expertise focused on enhancing product differentiation, patient engagement and clinical outcome measurement in real-world settings  
  • Ph.D. in physics from University College London 
  • MBE in technology management from The Open University  
  • Extensive background publishing and presenting at conferences on drug delivery, digital biomarkers, healthcare technology and technology licensing  
  • Associate lecturer of bioscience enterprise at the University of Cambridge  

 Phillips-Medisize brings decades of innovation to leading healthcare and life science companies—collaboratively developing groundbreaking solutions that help people live healthier, more productive lives. On average, Phillips-Medisize helps commercialize 50 new products annually, including the first-to-market FDA-registered drug delivery device using a connected health system.  

Ready to develop your innovative combination device right now? 

Learn How We Help

Talk to Us